Cabazitaxel and Radiation For Patients With Pathologically Determined Stage 3 Prostate Cancer and/or Patients With PSA Elevation (>0.1- < 2.0 ng/mL)
by on Friday, July 27th, 2012 | No Comments
Condition: Prostate Cancer
Intervention: Drug: Cabazitaxel
Sponsors: Brown University; Debora G. Isdale
Not yet recruiting – verified July 2012
See the original post: Cabazitaxel and Radiation For Patients With Pathologically Determined Stage 3 Prostate Cancer and/or Patients With PSA Elevation (>0.1- < 2.0 ng/mL)